SCHEMBL6359773

SCHEMBL6359773

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(S(=O)(=O)NCc2ccco2)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.64
KMT2A Q03164 8/20 0.64
ALDH1A1 P00352 2/20 0.64
MAPT P10636 4/20 0.58
TDP1 Q9NUW8 2/20 0.58
KDM4E B2RXH2 2/20 0.58
POLB P06746 1/20 0.58
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.53
TSHR P16473 1/20 0.52
GPR55 Q9Y2T6 1/20 0.52
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352806 0.85 MEN1 (0.61) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL6349137 0.82 MEN1 (0.47) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL1278912 0.78 MAPT (0.73) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL6352089 0.78 TP53 (0.49) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL17166275 0.75 AKR1C2 (0.73) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL6352622 0.75 KCNK2 (0.59) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL6349460 0.75 MEN1 (0.60) MEN1KMT2AMAPTPOLB
SCHEMBL6350610 0.75 MEN1 (0.69) MEN1KMT2AMAPT
SCHEMBL6358636 0.74 PRMT1 (0.50) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL6346641 0.74 METAP2 (0.58) MEN1KMT2AMAPTTDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MEN1 3274/4885KMT2A 3645/4885ALDH1A1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.